Marginal bone level changes and prosthetic maintenance of mandibular overdentures supported by 2 implants: a 5-year randomized clinical trial.
Documentation of early loading of mandibular overdentures supported by different implant systems is scarce. This study aimed to compare the biologic and prosthetic outcome of mandibular overdentures supported by unsplinted early-loaded one- and two-stage oral implants after 5 years of function. Twenty-eight consecutive patients were screened following an inclusion and exclusion criteria, and randomly allocated to treatment groups. Ball-retained mandibular overdentures were fabricated on two unsplinted Straumann (Institut Straumann AG, Basel, Switzerland) and Brånemark (Nobel Biocare AB, Göteborg, Sweden) dental implants and subjected to an early-loading protocol. During the 5-year period, prosthetic complications were recorded. At 5-years of function, plaque, peri-implant inflammation, bleeding, and calculus index scores were recorded, and standard periapical radiographs were obtained from each implant for measurement of marginal bone loss. All implants survived during the observation period. The peri-implant inflammation, bleeding, and calculus index scores around Straumann and Brånemark implants were similar (p > .05). The marginal bone loss around Brånemark implants (1.21 +/- 0.1) was higher than Straumann implants (0.73 +/- 0.06) at 5 years of function (p = .002). Kaplan-Meier tests revealed that 1- and 5-year survival of overdentures on Straumann and Brånemark implants were similar (p = .85). Wear of the ball abutment in the Brånemark group was higher than in the Straumann group (p < .05). Complications regarding the retainer and the need for occlusal adjustments were higher in the Straumann group (p < .05). Chi-square test revealed that the frequency of retightening of the retainer was higher in the Straumann group than in the Brånemark group (p < .05). Mandibular overdentures supported by unsplinted early-loaded Straumann and Brånemark implants lead to similar peri-implant soft tissue and prosthetic outcomes, although higher marginal bone loss could be observed around Brånemark implants after 5 years.